Search

Your search keyword '"Quarta L"' showing total 214 results

Search Constraints

Start Over You searched for: Author "Quarta L" Remove constraint Author: "Quarta L"
214 results on '"Quarta L"'

Search Results

1. Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates

2. POS0854 HOPELESSNESS LEVELS ARE SIGNIFICANTLY INCREASED IN SYSTEMIC SCLEROSIS PATIENTS AND CORRELATE WITH THE RAYNAUD CONDITION SCORE AND DIGITAL ULCER SEVERITY

3. PSA doubling time thresholds in predicting clinical recurrence after biochemical recurrence in surgically treated prostate cancer patients. The Impact of nodal status and adjuvant radiotherapy

4. Does the accuracy of PSA density change according to prostate volume? Assessing the diagnostic accuracy at the extreme values of prostate volume in a large single institution series

5. The quantification of GSP4 volume is superior to ISUP GG classification and %GSP4 for predicting adverse outcomes in radical prostatectomy patients

6. Defining intermediate-risk non-muscle invasive bladder cancer: A comparative study of EAU and IBCG criteria

7. Age-dependent effect of early salvage radiotherapy for biochemical recurrence in prostate cancer patients treated with radical prostatectomy

8. PSMA radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection: Updated results of a planned interim analysis of a prospective phase 2 study

9. Urological follow-up of Lynch syndrome: UTUC incidence and mutational patterns in a dedicated outpatient clinic

10. Cancer control rates in adequate versus inadequate treatment with adjuvant immunotherapy instillations with BCG

11. Long-term oncological outcomes of surgically managed very high-risk prostate cancer patients according to the STAMPEDE trial definition: Implications for the selection of candidates for clinical trials

12. Validation of the EAU risk groups for radical prostatectomy prostate cancer patients who experienced biochemical recurrence restaged with PSMA PET imaging and development of a novel tool

13. A novel PRECISE implemented predictive model to assess the risk of long-term disease reclassification in men on active surveillance. Results from a large, single institution series

14. The role of artificial intelligence for the detection of clinically significant prostate cancer at multiparametric magnetic resonance imaging

15. Optimizing the number of systematic cores during MRI target biopsy. Preliminary results from the prospective, paired-cohort SCOT Trial

16. The importance of high volume providers in the diagnostic pathways of prostate cancer. Results from large, singe Institution series

17. Towards a tailored use of PSA density to decide when to avoid prostate biopsy in men with PIRADS 3 lesions according to the location of the index lesion at mp-MRI. Results of a large, multi-institutional series

18. How can we reduce the rates of false positive findings at mpMRI? The pivotal role of urologist expertise assessed in a large, single center series

19. POS0857 EFFECTIVENESS AND SAFETY OF BIOLOGIC AND TARGET SYNTHETIC DRUGS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN THE ERA OF JAK INHIBITORS: A REAL-LIFE STUDY FROM BIOPURE REGISTRY

21. Growth hormone responses during arginine and clonidine stimulation test: correlations with patients’ auxological and metabolic parameters in a single centre study

22. When is central histological review of prostate biopsy really needed to reduce the risk of misclassification of prostate cancer? The importance of patient risk stratification

23. Oncologic outcomes of patients with incidental prostate cancer: Can we rely on multiparametric mri to exclude aggressive prostate cancer?

24. Added value of mpmri in the stratification of patients with high-risk patients prostate cancer treated with radical prostatectomy: implications for tailored multi-modal strategies

25. Does previous prostatic surgery affect the accuracy of multiparametric MRI in detecting clinically significant prostate cancer? Results from a single center, high volume series

26. Are extended pelvic lymph node dissection-related complications still an issue in contemporary patients treated with robot-assisted radical prostatectomy? a prospective assessment using a standardized collection system

27. The prognostic value of the number of positive targeted cores in men with positive multiparametric magnetic resonance imaging of the prostate. results from a large, multi-institutional series

28. The impact of frailty status on surgical outcomes after robot-assisted radical prostatectomy - a prospective assessment using a standardized collection system for perioperative outcomes

29. Increased awareness of surgical outcomes improves long-term functional outcomes after robot-assisted radical prostatectomy. A prospective assessment following implementation of prospective data collection

30. Does centralized revision of prostate biopsy impact on active surveillance outcomes? results from a single, high-volume institution series

31. The impact of histological variants on the performance characteristics of 68Ga-PSMA PET/CT in the primary and recurrent setting

32. Assessing the role of frailty status on oncologic and functional outcomes in patients treated with robot-assisted radical prostatectomy for localized prostate cancer

33. Histological variants of prostate cancer are under-reported in prostate biopsies assessed outside tertiary referral centers. a plea for biopsy review for optimal patient management

34. Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: A 12-month prospective observational study

35. POS0703 BIOLOGIC-DMARDS AND TARGETED SYNTHETIC-DMARDS EFFECT ON RAPID WITHDRAWAL OF STEROID IN 6 MONTHS OBSERVATIONAL PERIOD IN RHEUMATOID ARTHRITIS PATIENT’S COHORT: REAL LIFE DATA EXTRACTED FROM BIOPURE REGISTRY.

36. When is neoadjuvant androgen deprivation therapy beneficial for highly aggressive prostate cancer before radical prostatectomy? Implications for multi-modal tailored approaches and trials design

37. Are extended pelvic lymph node dissection-related complications still an issue in contemporary patients treated with robot-assisted radical prostatectomy? A prospective assessment using a standardized collection system

38. Assessing the role of frailty status on surgical, oncologic and functional outcomes in patients treated with robot-assisted radical prostatectomy for prostate cancer

42. A0716 - Does the accuracy of PSA density change according to prostate volume? Assessing the diagnostic accuracy at the extreme values of prostate volume in a large single institution series.

43. P311 - Towards a tailored use of PSA density to decide when to avoid prostate biopsy in men with PIRADS 3 lesions according to the location of the index lesion at mp-MRI. Results of a large, multi-institutional series.

47. AB1082 INFLUENCE OF THE VARIATION OF THE OPERATOR, PATIENT POSITION AND DEVICE ON THE MEASUREMENT PERFORMANCE OF RADIOFREQUENCY ECHOGRAPHIC MULTI SPECTROMETRY (REMS)

Catalog

Books, media, physical & digital resources